Purchase Order 75N92020P00265
Award Date 9/10/20
Potential Completion Date 9/10/21
Potential Value $148K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award from the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), is a firm fixed price delivery order issued to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The $26,672.00 award is for the provision of Illumina's proprietary sequencing instruments, reagents, and related consumables and services, including NextSeq, NovaSeq, MiSeq, and iSeq platforms, to support genomic research and...
- This firm fixed-price purchase order contract, awarded by the National Heart Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH), provides Illumina, Inc. with a NovaSeq X Plus sequencing system to support genomic research initiatives. The $999,999.00 contract has a completion date of September 19, 2024. Illumina is a leading manufacturer of genetic sequencing and analysis technologies, and has been awarded numerous federal contracts and grants to supply sequencing...
- This is a firm fixed-price delivery order awarded by the National Heart, Lung, and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), a civilian federal agency. The $42,511.56 contract is for Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, to provide Illumina sequencing kits and reagents to support next-generation DNA sequencing activities at the NHLBI Sequencing Core Facility. The contract has a performance period ending on...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Human Genome Research Institute awarded a firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents, to provide MiSeq and NovaSeq 600 sequencing services. The $110,226.52 contract has a completion date of June 4, 2024 and does not utilize any set-aside provisions. The contract was awarded on June 5, 2023 pursuant to a...
- This is a firm fixed-price delivery order awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The $48,994.05 contract is for the procurement of an Illumina MiSeq I100 sequencing system and associated reagents and services, to support high-quality DNA sequencing and genomic research at NHLBI. The contract has an ultimate...
- This $149,519.97 firm fixed price delivery order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Environmental Health Sciences to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The order is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample prep kits, and bioinformatics support. The contract does...
- This is a firm fixed-price delivery order awarded by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genomic sequencing systems and analytical instruments. The contract, valued at $149,982.23, is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance services,...
- This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Human Genome Research Institute to Illumina, Inc., a manufacturer of gene sequencing instruments and reagents. The $148,651.94 firm fixed price delivery order is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as associated reagents, consumables, and support services. This contract does not have a set-aside...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $130,000 purchase order to Illumina, Inc. for maintenance on the NovaSeq and MiSeq equipment used for sequencing services. The contract has a one-year period of performance from September 2021 through September 2022 and utilizes a firm fixed price contract type. Illumina will provide maintenance and support services on sequencing equipment located in San Diego, California...
- This is a firm-fixed price delivery order awarded by the Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The $149,473.04 contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with associated consumables, maintenance, and bioinformatics products. This contract does not have a...